Anti-PSGL-1 Antikörper

Patent europeic · EP2377890 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2377890
Numer da la dumonda
EP11150345
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-05-2005
Publitgà
19-10-2011
Concedì
10-08-2016
Stritgà
10-05-2025
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
C12N 15/13 (2006.01)
Prioritad
US 569892 P 10.05.2004
Derivà da
EP05747985
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 10-05-2025

    Durada maximala cuntanschida

    Status of protective title
    Active → Cancelled
    Cancellation date
    10.05.2025
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 10.05.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  4. 05-03-2021

    Transferì

    Owner
    AbGenomics Coöperatief U.A., Strawinskylaan 3111, 1077 ZX Amsterdam, Netherlands → AltruBio Inc., 1209 Orange Street, Wilmington, New Castle County, Delaware 19801, USA

    Published in Swissreg on 05.03.2021

  5. 10-08-2016

    Concedì

    Published in Swissreg on 10.08.2016

Partidas

Inventur

Lin, Rong-Hwa

Taipei 1, TW

Chang, Chung Nan

Foster City, CA 94404, US

Chen, Pei-Jiun

Taipei 234, TW

Huang, Chiu-Chen

Taipei 114, TW

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.